To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer

NCT00697619 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Cancer

Interventions

DRUG: Zometa (zoledronic acid)

Sponsor

Sun Yat-sen University

Collaborators

[object Object]